Predicted Trait | |
Reported Trait | Oral cavity and pharyngeal cancers |
Mapped Trait(s) |
Score Construction | |
PGS Name | CC_Oral_IV |
Development Method | |
Name | 14 variants from Graff et al (PGS000081) with inverse variant weights |
Parameters | NR |
Variants | |
Original Genome Build | GRCh37 |
Number of Variants | 14 |
Effect Weight Type | Inverse-variance weighting |
PGS Source | |
PGS Catalog Publication (PGP) ID | PGP000186 |
Citation (link to publication) | Kachuri L et al. Nat Commun (2020) |
Ancestry Distribution | |
Source of Variant Associations (GWAS) | |
PGS Evaluation | European: 100% 1 Sample Sets |
Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
---|---|---|---|
GWAS Catalog: GCST003857 Europe PMC: 27749845 |
1,183 individuals | Not reported | 7 cohorts
|
GWAS Catalog: GCST003857 Europe PMC: 27749845 |
11,436 individuals | European, NR | 7 cohorts
|
GWAS Catalog: GCST003859 Europe PMC: 27749845 |
736 individuals | Not reported | 7 cohorts
|
GWAS Catalog: GCST003859 Europe PMC: 27749845 |
8,490 individuals | European | 7 cohorts
|
GWAS Catalog: GCST003858 Europe PMC: 27749845 |
874 individuals | Not reported | 7 cohorts
|
GWAS Catalog: GCST001011 Europe PMC: 21437268 |
10,425 individuals | European | ARCAGE, B58C, CNG, IARCCES |
GWAS Catalog: GCST003858 Europe PMC: 27749845 |
8,701 individuals | European | 7 cohorts
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
---|---|---|---|---|---|---|---|---|
PPM002063 | PSS001020| European Ancestry| 391,479 individuals |
PGP000186 | Kachuri L et al. Nat Commun (2020) |
Reported Trait: Incident oral cavity and pharyngeal cancer | HR: 1.12 [1.02, 1.23] | AUROC: 0.702 C-index: 0.687 (0.015) |
R²: 0.356 | Age at assessment, sex, genotyping array, PCs(1-15), weekly alcohol intake, cigarettes per day, years of smoking, smoing status (never vs. former vs. current) | C-index calculated as a weighted average between 1 and 5 years and AUC at 5 years. |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
---|---|---|---|---|---|---|---|---|
PSS001020 | Individuals with at least one recorded incident diagnosis of a borderline, in situ, or malignant primary cancer were defined as cases. | — | [
|
— | European | — | UKB | — |